Table 3.
Disease-specific disability weightings, IHME Global Burden of Disease Study 2016 [33] unless otherwise stated
| Condition | Disability weight |
|---|---|
| Skin cancer | |
| Diagnosis and primary therapy phase of skin melanoma or other neoplasmsa | 0.29 (0.19–0.40) |
| Moderate disfigurement due to squamous cell carcinoma | 0.07 (0.04–0.10) |
| Disfigurement due to basal cell carcinoma | 0.01 (0.01–0.02) |
| Hernia | |
| Severe | 0.32 (0.22–0.44) |
| Moderate | 0.11 (0.08–0.16) |
| Cataract | |
| Severe vision loss | 0.18 (0.13–0.26) |
| Moderate vision loss | 0.03 (0.02–0.05) |
| Heart conditions | |
| Severe congenital heart disease and heart failure | 0.21 (0.15–0.29) |
| Moderate congenital heart disease and moderate heart failure | 0.07 (0.05–0.10) |
| Mild congenital heart disease and mild heart failure | 0.04 (0.03–0.06) |
| Epilepsy | |
| Severe epilepsy, > 1 seizure per month | 0.55 (0.38–0.71) |
| Less severe epilepsy, 1–11 seizures per year | 0.26 (0.17–0.37) |
| Gall bladder conditions | |
| Cholecystitis: severe symptomatic gallbladder disease | 0.32 (0.22–0.44) |
| Cholelithiasis: moderate symptomatic gallbladder disease | 0.11 (0.08–0.16) |
| Hypothyroidism or hyperthyroidism | |
| Moderate endocrine, metabolic, blood and immune disorders | 0.15 (0.10–0.20) |
| Kidney stones/nephritis | 0.11 (0.08–0.16) |
| Breast cancer | |
| Primary diagnosis and therapy phase | 0.29 (0.19–0.40) |
| Post-mastectomy | 0.08 (0.05–0.12) |
| Cryptorchidism | |
| Classified as other congenital birth defect | 0.22 (0.08–0.22) |